SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-046857
Filing Date
2011-08-15
Accepted
2011-08-15 13:14:51
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 v231955_10q.htm 10-Q 891022
2 v231955_ex31-1.htm EX-31.1 13498
3 v231955_ex31-2.htm EX-31.2 13400
4 v231955_ex32-1.htm EX-32.1 7275
5 v231955_ex32-2.htm EX-32.2 7624
  Complete submission text file 0001144204-11-046857.txt   2161005

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prtt-20110630.xml EX-101.INS 160450
7 XBRL TAXONOMY EXTENSION SCHEMA prtt-20110630.xsd EX-101.SCH 14677
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtt-20110630_cal.xml EX-101.CAL 22510
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtt-20110630_def.xml EX-101.DEF 85724
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtt-20110630_lab.xml EX-101.LAB 83317
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtt-20110630_pre.xml EX-101.PRE 91593
Mailing Address 759 BLOOMFIELD AVE SUITE 411 WEST CALDWELL NJ 07006
Business Address 759 BLOOMFIELD AVE SUITE 411 WEST CALDWELL NJ 07006 973-568-1617
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 111034763
SIC: 2834 Pharmaceutical Preparations